Sympathoinhibitory effects of atorvastatin in hypertension

Circulation Journal

Volumn 74, Issue 12, 2010, Pages 2552-2553

  Kishi, Takuya ^a   Hirooka, Yoshitaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ATORVASTATIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NITRIC OXIDE; NORADRENALIN; PLACEBO; REACTIVE OXYGEN METABOLITE; SIMVASTATIN; SUPEROXIDE;

ADRENERGIC ACTIVITY; ADRENERGIC NERVE CELL; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; BIOAVAILABILITY; BLOOD BRAIN BARRIER; CLINICAL TRIAL; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; DRUG MECHANISM; DRUG PENETRATION; EDITORIAL; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HEART FAILURE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; LIPOPHILICITY; MEDULLA OBLONGATA; NONHUMAN; NORADRENALIN BLOOD LEVEL; OXIDATIVE STRESS; PRESSORECEPTOR REFLEX; SCIENTIFIC LITERATURE; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC BLOCKING; UPREGULATION;

ADOLESCENT; ADULT; AGED; ANIMALS; BLOOD PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; MALE; MIDDLE AGED; NOREPINEPHRINE; PROSPECTIVE STUDIES; PYRROLES; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS;

EID: 78649705224     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-1024     Document Type: Editorial

References (15)

1. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481-487.
2. Masumoto A, Hirooka Y, Hironaga K, Eshima K, Setoguchi S, Egashira K, et al. Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin). Am J Cardiol 2001; 88: 1291-1294.
3. Golomb BA, Dimsdale JE, White HL, Ritchie JB, Criqui MH. Reduction in blood pressure with statins: Results from the USCD Statin Study, a randomized trial. Arch Intern Med 2008; 168: 721-727.
4. Dampney RAL. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994; 74: 323-364.
5. Kishi T, Hirooka Y, Sakai K, Shigematsu H, Shimokawa H, Takeshita A. Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release. Hypertension 2001; 38: 896-901.
6. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 2004; 109: 2357-2362.
7. Hirooka Y, Sagara Y, Kishi T, Sunagawa K. Oxidative stress and central cardiovascular regulation: Pathogenesis of hypertension and therapeutic aspects. Circ J 2010; 74: 827-835.
8. Kishi T, Hirooka Y, Mukai Y, Shimokawa H, Takeshita A. Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats. J Hypertens 2003; 21: 379-386.
9. Kishi T, Hirooka Y, Shimokawa H, Takeshita A, Sunagawa K. Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 2008; 30: 3-11.
10. Kishi T, Hirooka Y, Konno S, Sunagawa K. Atorvastatin improves the impaired baroreflex sensitivity via anti-oxidant effect in the rostral ventrolateral medulla of SHRSP. Clin Exp Hypertens 2009; 31: 698-704.
11. Kishi T, Hirooka Y, Konno S, Sunagawa K. Sympathoinhibition induced by centrally administered atorvastatin is associated with alteration of NAD(P)H and Mn superoxide dismutase activity in rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 2010; 55: 184-190.
12. Gomes ME, Tack CJ, Verheugt FW, Smiths P, Lenders JWM. Sympathoinhibition by atorvastatin in hypertensive patients. Circ J 2010; 74: 2622-2626.
13. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, et al. Simvastatin therapy normalizes sympathetic neural control in experimental heart failure. Circulation 2005; 112: 1763-1770.
14. Cibickova L, Hyspler R, Ticha A, Cibicek N, Palicka V, Cermakova E, et al. Cholesterol synthesis in central nervous system of rat is affected by simvastatin as well as by atorvastatin. Pharmazie 2008; 63: 819-822.
15. Grassi G. Sympathetic neural activity in hypertension and related diseases. Am J Hypertens 2010; 23: 1052-1060.